MoonLake Immunotherapeuti... (MLTX)
36.37
-2.70 (-6.91%)
At close: Apr 01, 2025, 3:59 PM
36.35
-0.04%
After-hours: Apr 01, 2025, 04:05 PM EDT
MoonLake Immunotherapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
73
Upside
100.74
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| RBC Capital | Buy | Initiates | 67 | 84.24% | Mar 18, 2025 | |
| Goldman Sachs | Buy | Maintains | 82 73 | 100.74% | Feb 27, 2025 | |
| HC Wainwright & Co. | Buy | Reiterates | 100 100 | 174.99% | Feb 27, 2025 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.